Search
Now showing items 1-10 of 35
Branch Retinal Vein Occlusion Associated With Platelet Activation
(2019)
Background/aim: The aim of this study is to study subclinical platelet activation by detecting three important platelet activation parameters of mean platelet volume (MPV), platelet distribution width (PDW), and plateletcrit ...
Indications And Outcomes Of Splenectomy For Hematological Disorders
(2019)
Background and Aim Splenectomy is a frequent component of the diagnosis and treatment of hematological disorders. The aim of this study was to define the indications and outcomes of splenectomy for benign and malign ...
Effects Of Ankaferd Hemostat On Helicobacter Pylori Strains And Antibiotic Resistance
(2019)
Background/aim: Ankaferd hemostat (ABS; Ankaferd blood stopper, Istanbul, Turkey) is a folkloric medicinal plant extract. The aim of this study was to determine the effect of Ankaferd hemostat (ABS) on the fate of Helicobacter ...
Discontinuation Of Imatinib Mesylate Could Improve Renal Impairment In Chronic Myeloid Leukemia
(2019)
We aim to report a CML case that had fluid retention and serum creatinine increase under long-term imatinib mesylate (IM) treatment. A 68-year-old woman was diagnosed with chronic myeloid leukemia, and IM was started in ...
Splenic Artery Embolization With Ankaferd Blood Stopper In A Sheep Model
(Aves, 2016)
PURPOSE Splenic artery embolization is a minimally invasive therapeutic procedure utilized in a number of disorders. Ankaferd blood stopper (ABS) is a novel hemostatic agent with a new mechanism of action independent of ...
Generation Of Chimeric “Abs Nanohemostat” Complex And Comparing Its Histomorphological In Vivo Effects To The Traditional Ankaferd Hemostat In Controlled Experimental Partial Nephrectomy Model
(2013)
Purpose. Using the classical Ankaferd Blood Stopper (ABS) solution to create active hemostasis during partial nephrectomy (PN) may not be so effective due to insufficient contact surface between the ABS hemostatic liquid ...
Hemostatic Efficacy Of Ankaferd Blood Stopper (R) In A Swine Bleeding Model
(Karger, 2009)
Objective: The purpose of this study was to show the hemostatic effect of spray, solution and tampon forms of Ankaferd Blood Stopper (R) (ABS), a unique medicinal plant extract historically used as a hemostatic agent in ...
Monitoring The Response To Tyrosine Kinase Inhibitor (Tki) Treatment In Chronic Myeloid Leukemia (Cml)
(2014)
The aim of oral tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML) is to get ideal hematological, cytogenetic, molecular responses at the critical time points. The depth of the response obtained ...
Ankaferd Blood Stopper Is More Effective Than Adrenaline Plus Lidocaine And Gelatin Foam In The Treatment Of Epistaxis In Rabbits
(Elsevier Science Inc, 2011)
BACKGROUND: Epistaxis is an important emergency that can sometimes be life threatening without effective intervention. Persistent and recurrent bleeding can lead to aspiration, hypotension, hypoxia, or even severe and ...
